Key result
Chemical cross-linking and mass spectrometry revealed one WASP binding site on the back side of Arp3 and a second site on the bottom of the complex spanning Arp2 and ARPC1.
The study maps the WASP binding sites on the Arp2/3 complex, supporting the Arp3 tail release model for WASP-mediated activation.
Structural models advance WASP-Arp2/3 binding understanding; leaves open validation in cellular motility and endocytosis.
Arp2/3 complex nucleates branched actin filaments important for cellular motility and endocytosis. WASP family proteins are Arp2/3 complex activators that play multiple roles in branching nucleation, but little is known about the structural bases of these WASP functions, owing to an incomplete understanding of how WASP binds Arp2/3 complex. Recent data show WASP binds two sites, and biochemical and structural studies led to models in which the WASP C segment engages the barbed ends of the Arp3 and Arp2 subunits while the WASP A segment binds the back side of the complex on Arp3. However, electron microscopy reconstructions showed density for WASP inconsistent with these models on the opposite (front) side of Arp2/3 complex. Here we use chemical cross-linking and mass spectrometry (XL-MS) along with computational docking and structure-based mutational analysis to map the two WASP binding sites on the complex. Our data corroborate the barbed end and back side binding models and show one WASP binding site on Arp3, on the back side of the complex, and a second site on the bottom of the complex, spanning Arp2 and ARPC1. The XL-MS-identified cross-links rule out the front side binding model and show that the A segment of WASP binds along the bottom side of the ARPC1 subunit, instead of at the Arp2/ARPC1 interface, as suggested by FRET experiments. The identified binding sites support the Arp3 tail release model to explain WASP-mediated activating conformational changes in Arp2/3 complex and provide insight into the roles of WASP in branching nucleation.
No takes yet. Share an insight, caveat, or question.
Luan et al. (2018) studied this question. Chemical cross-linking and mass spectrometry (XL-MS) was evaluated on WASP binding sites on the Arp2/3 complex. Chemical cross-linking and mass spectrometry revealed one WASP binding site on the back side of Arp3 and a second site on the bottom of the complex spanning Arp2 and ARPC1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: